Jenkem Technology Co

Jenkem Technology Co Quick Ratio

The Quick Ratio (Acid Test) of Jenkem Technology Co (688356.SS) as of Oct 17, 2026 is 3.75. In the previous year, Quick Ratio (Acid Test) was 6.47 — a change of -42.08% (lower).

Quick Ratio

3.75

YoY

-42.08%

Last updated:

Quick Ratio (Acid Test) of Jenkem Technology Co is 2025 3.75 . Quick Ratio (Acid Test) of Jenkem Technology Co was 2024 6.47 . It decreases by -42.08% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jenkem Technology Co Stock analysis

What does Jenkem Technology Co do? Jenkem Technology Co Ltd is a pharmaceutical company based in Beijing, China, operating within the healthcare sector. The company focuses on the research, development, production, and sales of medical polyethylene glycol (PEG) and its active derivatives. With 252 employees, Jenkem Technology serves various industries including drug and medical device manufacturing, scientific research institutions, and other related fields. The company went public on the Shanghai Stock Exchange on August 26, 2020, with the ticker symbol 688356.SS. Its primary products are utilized in the development and production processes of pharmaceuticals and medical technologies. Jenkem Technology also provides technical services such as patent and non-patent technology licensing, as well as research and development support. The company's headquarters are located in Beijing, and it maintains a corporate website at www.jenkem.com. Jenkem Technology operates as a publicly traded entity, offering its services and products primarily to the healthcare and research sectors. The firm's activities are centered around the production and application of PEG-based materials, which are essential in various medical and scientific applications. The company's operational scope includes both domestic and international markets, though specific market details are not provided. Jenkem Technology's business model emphasizes innovation in medical materials, particularly through its focus on PEG and its derivatives. The company's IPO date marks a significant milestone in its growth trajectory, reflecting its transition to a publicly listed entity. The firm's product portfolio and services are designed to support the broader healthcare industry's needs in research and development. Jenkem Technology's operations are grounded in the production of key materials used in pharmaceutical and medical device manufacturing, contributing to advancements in healthcare technology. Jenkem Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jenkem Technology Co stock

Quick Ratio (Acid Test) of Jenkem Technology Co is 3.75 in 2025.

Quick Ratio (Acid Test) of Jenkem Technology Co changed from 6.47 to 3.75, representing a -42.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Jenkem Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Jenkem Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Jenkem Technology Co

All Key Metrics — Jenkem Technology Co